Synopsis
Synopsis
0
FDF
0
FDA Orange Book
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Clenbuterol
2. Nab 365
3. Nab-365
4. Nab365
5. Planipart
1. 21898-19-1
2. Clenbuterol Hcl
3. Spiropent
4. Ventipulmin
5. Clenbuterol Clorhidrato
6. Nab-365
7. Nab-365cl
8. Gor5747gwu
9. 1-(4-amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol;hydrochloride
10. Mls000069838
11. Nab 365 Cl
12. Chebi:31410
13. Smr000058854
14. 21898-19-1 (hcl)
15. 1-(4-amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol Hydrochloride
16. 4-amino-alpha-(tert-butylaminomethyl)-3,5-dichlorobenzyl Alcohol Hydrochloride
17. 4-amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl Alcohol Hydrochloride
18. Sr-01000721909
19. Contrasmina
20. Clenasma
21. Siropent
22. Spiropent (tn)
23. Prestwick_761
24. Planipart Hydrochloride
25. Clenbuterolhydrochloride
26. 4-amino-.alpha.-((tert-butylamino)methyl)-3,5-dichlorobenzyl Alcohol
27. Opera_id_146
28. Unii-gor5747gwu
29. Clenbuterol Monohydrochloride
30. Mls001148242
31. Mls002222258
32. Clenbuterol Hydrochloride,(s)
33. Schembl123545
34. Spectrum1503917
35. (+-)-clenbuterol Hydrochloride
36. Chembl1330729
37. Clenbuterol Clorhidrato [spanish]
38. Clenbuterol Hydrochloride Solution
39. Dtxsid60944496
40. Regid_for_cid_5702273
41. Clenbuterol Hydrochloride, >=95%
42. Hms1569e11
43. Pharmakon1600-01503917
44. (+-)-clenbuterol Monohydrochloride
45. Bcp13609
46. Hy-b1614
47. Einecs 244-643-7
48. Einecs 274-226-5
49. Ccg-39893
50. Clenbuterol Hydrochloride (jan/usp)
51. Clenbuterol Hydrochloride [usp:jan]
52. Mfcd00083280
53. Nsc758633
54. Clenbuterol Hydrochloride [mi]
55. Akos007930709
56. Am84776
57. Clenbuterol Hydrochloride [jan]
58. Cs-6917
59. Clenbuterol Hydrochloride [mart.]
60. Ncgc00095982-01
61. Ac-11159
62. As-12537
63. Clenbuterol Hydrochloride [usp-rs]
64. Clenbuterol Hydrochloride [who-dd]
65. Clenbuterol Hydrochloride [green Book]
66. Vu0244438-4
67. Clenbuterol Hydrochloride [ep Impurity]
68. Clenbuterol Hydrochloride [ep Monograph]
69. D01360
70. F17351
71. Clenbuterol Hydrochloride [usp Monograph]
72. Clenbuterol Hydrochloride 100 Microg/ml In Ethanol
73. Clenbuterol Hydrochloride 1000 Microg/ml In Ethanol
74. Q-200872
75. Sr-01000721909-4
76. Sr-01000721909-5
77. 1-(4-amino-3,5-dichlorophenyl)-2-(tert-butylamino)
78. Q27114305
79. Clenbuterol Hydrochloride 1.0 Mg/ml In Dimethyl Sulfoxide (as Free Base)
80. Clenbuterol Hydrochloride, European Pharmacopoeia (ep) Reference Standard
81. (1)-4-amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl Alcohol Monohydrochloride
82. 4-amino-3,5-dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol Hydrochloride
83. 4-amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl Alcohol Monohydrochloride
84. 4-amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl Alcoholmonohydrochloride
85. 4-amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzylalkohol-hydrochlorid
86. 4-amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzylalkohol-hydrochlorid [german]
87. Benzyl Alcohol, 4-amino-alpha-((tert-butylamino)methyl)-3,5-dichloro-, Monohydrochloride
88. Clenbuterol Hydrochloride, United States Pharmacopeia (usp) Reference Standard
89. 4-amino-3,5-dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol Monohydrochloride
90. Clenbuterol Hydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
Molecular Weight | 313.6 g/mol |
---|---|
Molecular Formula | C12H19Cl3N2O |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 4 |
Exact Mass | 312.056296 g/mol |
Monoisotopic Mass | 312.056296 g/mol |
Topological Polar Surface Area | 58.3 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 233 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Adrenergic beta-Agonists
Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
Certificate Number : R0-CEP 2020-172 - Rev 01
Issue Date : 2022-07-28
Type : Chemical
Substance Number : 1409
Status : Valid
Date of Issue : 2022-06-13
Valid Till : 2025-07-02
Written Confirmation Number : WC-0155
Address of the Firm :
NDC Package Code : 66412-0417
Start Marketing Date : 2021-01-05
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40743
Submission : 2024-12-09
Status : Active
Type : II
VMF Number : 6258
Submission : 2018-07-31
Status : Active
Type : II